Aratana to Present at Bank of America Merrill Lynch Animal Health Summit

   Aratana to Present at Bank of America Merrill Lynch Animal Health Summit

PR Newswire

KANSAS CITY, Kan., Dec. 7, 2012

KANSAS CITY, Kan., Dec. 7, 2012 /PRNewswire/ -- Aratana Therapeutics, a
biopharmaceutical company developing innovative medicines for cats and dogs
(companion animals), today announced that it will participate in Bank of
America Merrill Lynch's Animal Health Summit, taking place December 11, 2012,
at the Bank of America Conference Center in Boston, MA.

Steven St. Peter, M.D., President and Chief Executive Officer of Aratana, will
present a company overview at 2pm ET, and will also host one-on-one and small
group meetings with investors. Dr. St. Peter will be joined by Louise
Mawhinney, CPA, Chief Financial Officer, and Linda Rhodes, V.M.D., Ph.D.,
Chief Scientific Officer of Aratana Therapeutics.

About Aratana Therapeutics
Aratana Therapeutics is a biopharmaceutical company positioned to deliver high
quality new medicines that address significant therapeutic needs for cats and
dogs (companion animals). Aratana licenses and develops proprietary,
patent-protected compounds acquired from human pharmaceutical and
biotechnology companies and then develops strategies to maximize the value of
the programs for the animal health market. For more information, please visit

For Investors & Media:
Joshua Drumm, Ph.D. / Andrew Mielach
Tiberend Strategic Advisors, Inc.
(212) 827-0020

SOURCE Aratana Therapeutics

Press spacebar to pause and continue. Press esc to stop.